Does ethnic diversity explain intra-UK variation in mortality? A longitudinal cohort study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
30 03 2019
Historique:
entrez: 1 4 2019
pubmed: 1 4 2019
medline: 17 3 2020
Statut: epublish

Résumé

It has been proposed that part of the explanation for higher mortality in Scotland compared with England and Wales, and Glasgow compared with other UK cities, relates to greater ethnic diversity in England and Wales. We sought to assess the extent to which this excess was attenuated by adjusting for ethnicity. We additionally explored the role of country of birth in any observed differences. Scotland and England and Wales; Glasgow and Manchester. We used the Scottish Longitudinal Study and the Office for National Statistics Longitudinal Study of England and Wales (2001-2010). Participants (362 491 in total) were aged 35-74 years at baseline. Risk of all-cause mortality between 35 and 74 years old in Scotland and England and Wales, and in Glasgow and Manchester, adjusting for age, gender, socioeconomic position (SEP), ethnicity and country of birth. 18% of the Manchester sample was non-White compared with 3% in Glasgow (England and Wales: 10.4%; Scotland: 1.2%). The mortality incidence rate ratio was 1.33 (95% CI 1.13 to 1.56) in Glasgow compared with Manchester. This reduced to 1.25 (1.07 to 1.47) adjusting for SEP, and to 1.20 (1.02 to 1.42) adjusting for ethnicity and country of birth. For Scotland versus England and Wales, the corresponding figures were 18% higher mortality, reducing to 10%, and then 7%. Non-Whites born outside the UK had lower mortality. In the Scottish samples only, non-Whites born in the UK had significantly higher mortality than Whites born in the UK. The research supports the hypothesis that ethnic diversity and migration from outside UK play a role in explaining Scottish excess mortality. In Glasgow especially, however, a large excess remains: thus, previously articulated policy implications (addressing poverty, vulnerability and inequality) still apply.

Identifiants

pubmed: 30928935
pii: bmjopen-2018-024563
doi: 10.1136/bmjopen-2018-024563
pmc: PMC6475238
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e024563

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Public Health (Oxf). 2009 Sep;31(3):324-5
pubmed: 19589801
Am J Public Health. 2000 Nov;90(11):1694-8
pubmed: 11076232
J Public Health (Oxf). 2005 Jun;27(2):199-204
pubmed: 15774571
BMC Public Health. 2013 May 10;13:458
pubmed: 23663279
Heart. 2012 Mar;98(6):468-73
pubmed: 22285972
Am J Public Health. 2001 Mar;91(3):392-9
pubmed: 11236403
Soc Sci Med. 2009 Oct;69(7):983-91
pubmed: 19525050
Am J Public Health. 2003 Feb;93(2):277-84
pubmed: 12554585
Int J Epidemiol. 2010 Oct;39(5):1372-82
pubmed: 20630989
Ann Epidemiol. 2008 May;18(5):351-6
pubmed: 18346910
Public Health. 2017 Oct;151:1-12
pubmed: 28697372
Public Health. 2012 May;126(5):378-85
pubmed: 22480713
J Epidemiol Community Health. 2017 May;71(5):493-498
pubmed: 28270504
Public Health. 2010 Sep;124(9):487-95
pubmed: 20223487
Popul Trends. 2010 Spring;(139):4-10
pubmed: 20379275
J Epidemiol Community Health. 2014 Jan;68(1):83-92
pubmed: 24129609
Am J Public Health. 2013 May;103(5):813-21
pubmed: 23488505
J Public Health (Oxf). 2012 Jun;34(2):296-304
pubmed: 21994434
PLoS Med. 2018 Mar 1;15(3):e1002515
pubmed: 29494587
BMJ. 2008 May 10;336(7652):1052-5
pubmed: 18403500
Am J Public Health. 2002 Apr;92(4):624-31
pubmed: 11919063
Int J Epidemiol. 2014 Feb;43(1):129-39
pubmed: 24355746
Int J Epidemiol. 2009 Apr;38(2):385-92
pubmed: 18492728
Ann N Y Acad Sci. 1999;896:120-30
pubmed: 10681893
Int J Epidemiol. 2011 Oct;40(5):1168-75
pubmed: 20657021
J Public Health (Oxf). 2011 Sep;33(3):453-8
pubmed: 21493620
Health Place. 2016 Jul;40:106-15
pubmed: 27235691
J Epidemiol Community Health. 2014 Dec;68(12):1133-44
pubmed: 25096809
J Epidemiol Community Health. 2015 Jan;69(1):20-7
pubmed: 25216666
Eur J Public Health. 2015 Feb;25(1):84-9
pubmed: 25201902

Auteurs

Lauren Schofield (L)

Information Services Division, Edinburgh, UK.

David Walsh (D)

Glasgow Centre for Population Health, Glasgow, UK.

Zhiqiang Feng (Z)

University of Edinburgh, Edinburgh, UK.

Duncan Buchanan (D)

ISD Scotland, Edinburgh, UK.

Chris Dibben (C)

University of Edinburgh, Edinburgh, UK.

Colin Fischbacher (C)

Information Services Division, Edinburgh, UK.

Gerry McCartney (G)

NHS Health Scotland, Glasgow, UK.

Rosalia Munoz-Arroyo (R)

Information Services Division, Edinburgh, UK.

Bruce Whyte (B)

Glasgow Centre for Population Health, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH